Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income attributable to common shares	$ 6,316,615	$ 7,596,575
Amortization (accretion) of investments	(3,964,398)	(7,530,201)
Realized investment (gains) losses, net	(11,562,629)	640,538
Unrealized trading gains included in income	1,604,757	(1,803,729)
Amortization of deferred policy acquisition costs	68,692	90,568
Amortization of cost of insurance acquired	1,231,015	1,324,731
Depreciation	1,412,661	1,311,029
Net income attributable to noncontrolling interest	186,669	786,337
Charges for mortality and administration of universal life and annuity products	(7,353,389)	(7,709,727)
Interest credited to account balances	5,152,218	5,247,365
Change in accrued investment income	472,684	(32,226)
Change in reinsurance receivables	2,757,683	2,265,937
Change in policy liabilities and accruals	(5,037,087)	(4,007,032)
Change in income taxes receivable/payable	(4,535,859)	277,669
Change in other assets and liabilities, net	2,763,164	(1,444,129)
Net cash used in operating activities	(10,487,204)	(2,986,295)
Cash flows from investing activities:
Fixed maturities available for sale	173,221,329	24,718,790
Equity securities available for sale	3,572,456	948,385
Trading securities	29,733,306	163,891,508
Mortgage loans	3,139,903	16,431,689
Discounted mortgage loans	15,032,186	23,607,100
Real estate	29,621,068	2,709,233
Policy loans	4,299,197	3,468,202
Short-term investments	0	700,000
Total proceeds from investments sold and matured	258,619,445	236,474,907
Cost of investments acquired:
Fixed maturities available for sale	(128,598,767)	(28,947,923)
Equity securities available for sale	(727,258)	(1,333,942)
Trading securities	(19,626,789)	(171,842,107)
Mortgage loans	(1,235)	(2,489,523)
Discounted mortgage loans	(11,122,151)	(38,323,757)
Real estate	(15,842,681)	(1,778,281)
Policy loans	(3,635,407)	(3,100,615)
Total cost of investments acquired	(179,554,288)	(247,816,148)
Purchase of property and equipment	214,475	139,291
Net cash provided by (used in) investing activities	78,850,682	(11,480,532)
Cash flows from financing activities:
Policyholder contract deposits	6,213,174	6,632,125
Policyholder contract withdrawals	(5,851,344)	(6,232,871)
Proceeds from notes payable/line of credit	7,943,000	7,290,000
Payments of principal on notes payable/line of credit	(8,783,594)	(11,320,650)
Purchase of treasury stock	(475,547)	(349,675)
Proceeds from sale of subsidiary	164,327	0
Distributions to minority interests of consolidated subsidiaries	3,131,271	561,493
Net cash used in financing activities	(3,921,255)	(4,542,564)
Net increase (decrease) in cash and cash equivalents	64,442,223	(19,009,391)
Cash and cash equivalents at beginning of period	18,483,452	37,492,843
Cash and cash equivalents at end of period	$ 82,925,675	$ 18,483,452